MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF) has achieved a significant milestone in workplace safety technology with the completion and delivery of its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes. The company is advancing its efforts to commercialize voice-based impairment detection technology, which could transform how safety-sensitive industries screen for alcohol, drug, or fatigue-related impairment.
The kiosks utilize artificial intelligence to analyze short voice samples, examining more than 140 acoustic markers associated with potential impairment. The AI models have been trained on over 50 million data points, allowing for high accuracy in predicting intoxication. The prototypes are now entering testing, validation, and data-analysis phases, involving industry participants, speech specialists, and software engineers to refine predictive models and assess real-world performance.
MindBio is targeting industries where large workforces and operational risks make conventional testing methods—such as breath, saliva, urine, and laboratory tests—costly and time-consuming. These sectors include mining, aviation, construction, transportation, and law enforcement. The company’s approach is designed to provide rapid, scalable, and less invasive initial screening. Individuals flagged for potential impairment can then undergo additional evaluation using established testing protocols.
“The completion of these prototypes marks a critical step toward bringing our technology to market,” said a company spokesperson. “We believe our Edge AI kiosks can help employers enhance safety while reducing the logistical and financial burdens of traditional testing.”
The importance of this development lies in its potential to address a pressing need in high-risk work environments. Impairment due to alcohol, drugs, or fatigue is a leading cause of workplace accidents, and current screening methods often require significant time and resources. Voice-based detection offers a non-invasive and rapid alternative that could be deployed at scale, allowing for frequent checks without disrupting operations.
MindBio’s technology also has implications for law enforcement and transportation, where quick and accurate impairment detection can enhance public safety. The company’s enterprise platform includes Edge-AI kiosks integrating bespoke hardware and software for detection in various environments.
For more information about MindBio Therapeutics and its technology, visit the company’s website at www.MindBioTherapeutics.com. The latest news and updates regarding MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF.
As the prototypes undergo further testing, the industry will be watching closely to see if voice-based AI can deliver on its promise of making workplaces safer and more efficient.
